[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365132-105":59,"doc-detail-365132-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-lncrna-panel-within-epcam-specific-exosomes-for-noninvasive-early-diagnosing-non-small-cell-lung-cancer","A LncRNA panel within EpCAM-specific exosomes for noninvasive early diagnosing non-small cell lung cancer","","Plasma tumor-associated exosomes are explored as a promising source of cancer biomarkers, but the contribution of long non-coding RNAs (lncRNAs) within these exosomes remains unclear for non-small cell lung cancer (NSCLC). A panel of NSCLC-specific lncRNAs in EpCAM-specific exosomes (Epexo) was derived from comparative lncRNA profiling between plasma Epexo and lung tissues, then assessed in retrospective and prospective cohorts using random-forest ROC analysis and repeat testing for precision.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-lncrna-panel-within-epcam-specific-exosomes-for-noninvasive-early-diagnosing-non-small-cell-lung-cancer/365132/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-lncrna-panel-within-epcam-specific-exosomes-for-noninvasive-early-diagnosing-non-small-cell-lung-cancer/365132.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",22,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What biological material and biomarker type does the study focus on?","Question",{"text":113,"@type":114},"The study focuses on long non-coding RNAs (lncRNAs) located within EpCAM-specific exosomes in plasma, targeting non-small cell lung cancer (NSCLC) as potential diagnostic biomarkers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the lncRNA panel developed and validated?",{"text":118,"@type":114},"The panel was identified by comparing lncRNA profiles between plasma EpCAM-specific exosomes (Epexo) and lung tissues, then evaluated in a retrospective cohort and validated in a prospective cohort.",{"name":120,"@type":111,"acceptedAnswer":121},"What diagnostic performance did the lncRNA panel achieve?",{"text":122,"@type":114},"The panel distinguished early-stage NSCLC from controls with AUC values of 0.805 in the discovery set and 0.856 in the validation set, supported by repeat testing consistency of 90.3%.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},365132,1790534205,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Liu et al. Respiratory Research (2025) 26:144 [https://doi.org/10.1186/s12931-025-03220-x](https://doi.org/10.1186/s12931-025-03220-x)  \nRespiratory Research  \nRESEARCH Open Access  \nA LncRNA panel within EpCAM-specific exosomes for noninvasive early diagnosing non-small cell lung cancer  \nLinyuan Liu 1†, Danlei Li 1†, Amei Zhuo 1†, Jiachun Lu 1,2,3, Jianjun Zou 1,4, Guitian Huang5, Zhaoting Hu6, Zili Zhang 1, Yibin Deng2* and Lei Yang 1,2,3*  \nAbstract  \nBackground Plasma tumor-associated exosomes represent a promising source for cancer biomarkers; however, the role of long non-coding RNAs (lncRNAs) within these exosomes is not well-defined in non-small cell lung cancer (NSCLC) .  \nMethods We identified a panel of NSCLC-specific lncRNAs within plasma EpCAM-specific exosomes (Epexo) through a comparative analysis of lncRNA profiles between plasma Epexo and lung tissues. The panel’s diagnostic value was firstly evaluated in a retrospective cohort of 210 NSCLC patients and 245 healthy controls, and validated in a prospective cohort of 192 patients with pulmonary nodules (nodule size \u003C 3 cm in diameter) . The evaluation utilized the area under the ROC curve (AUC) based on a random forest model. For precision, repeat testing was conducted with 31 randomly selected samples. Additionally, 39 paired tissue-plasma samples were employed to assess the concordance of lncRNA expression between tissue and plasma within the same individuals.  \nResults The panel, including linc01125, HNF1A-AS1, MIR100HG, linc01160, and ZNRF3-AS1, demonstrated superior capability in distinguishing early-stage NSCLC patients from controls, achieving AUC values of 0.805 and 0.856 in the discovery and validation set, respectively. The panel also showed potential for differentiating adenocarcinoma and squamous cell carcinoma. Repeat sample testing showed a consistency of 90 . 3% for this panel. The expression levels of MIR100HG and HNF1A-AS1 showed significant correlations between plasma Epexo and cancerous tissues. Conclusions The identified lncRNA panel, consisting of linc01125, HNF1A-AS1, MIR100HG, linc01160, and  \nZNRF3-AS1, presents a promising diagnostic tool for NSCLC.  \nClinical trial number not applicable.  \nKeywords EpCAM-specific exosomes, Long non-coding RNA, Non-small cell lung cancer, Pulmonary nodule  \n†Linyuan Liu, Danlei Li and Amei Zhuo contributed equally to this work.  \n*Correspondence:  \nYibin Deng [dengyb75@163.com](dengyb75@163.com)[ ](dengyb75@163.com)Lei Yang [leiyang@gzhmu.edu.cn](leiyang@gzhmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nLiu et al. Respiratory Research (2025) 26:144  \nBackground  \nLung cancer has been the leading cause of cancer-related death for years [1, 2]. Despite significant advancements in the treatment of lung cancer in the past decade, the fiveyear survival rate remains low at only 25.4%, according to the Surveil","cbCaiiDo2oswO4O9","https://ap.wps.com/l/cbCaiiDo2oswO4O9","pdf",6798941,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Lung cancer burden and need for early detection\n## Exosomes and biomarker potential","[{\"question\":\"What biological material and biomarker type does the study focus on?\",\"answer\":\"The study focuses on long non-coding RNAs (lncRNAs) located within EpCAM-specific exosomes in plasma, targeting non-small cell lung cancer (NSCLC) as potential diagnostic biomarkers.\"},{\"question\":\"How was the lncRNA panel developed and validated?\",\"answer\":\"The panel was identified by comparing lncRNA profiles between plasma EpCAM-specific exosomes (Epexo) and lung tissues, then evaluated in a retrospective cohort and validated in a prospective cohort.\"},{\"question\":\"What diagnostic performance did the lncRNA panel achieve?\",\"answer\":\"The panel distinguished early-stage NSCLC from controls with AUC values of 0.805 in the discovery set and 0.856 in the validation set, supported by repeat testing consistency of 90.3%.\"}]","A LncRNA panel within EpCAM-specific exosomes for noninvasive early diagnosing non-small cell lung cancer | PDF",1790160130,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6cb8805f3b4d5751b98b64c089069fa.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b7ecfd3fcf02b0c2ffec5688d296b12.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b26fe34f795dd5d559d3a7a72bc974c4.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f98d46215d5a85155dd8522f0bef783.webp",980,1306]